PrEP Intervention Among Black Sexual Minority Men
Launched by GEORGE MASON UNIVERSITY · Nov 15, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help Black sexual minority men in Prince George's County, Maryland, start and stick with a medication called PrEP, which can help prevent HIV. The researchers will create a supportive community program that addresses issues like internalized homophobia, racism, and stigma around HIV. Participants will join events designed to reduce stigma and build a strong community among Black queer men. The study will compare those who take part in these events with those who do not to see if the program helps more people begin and continue using PrEP.
To be eligible for this trial, you need to be a Black man, at least 18 years old, and HIV-negative. You should either live in Prince George's County or have had a sexual partner from there in the past year. If you are HIV-positive or refuse HIV testing, you won't be able to participate. If you join, you can expect to engage in activities aimed at promoting understanding and support around HIV prevention in a friendly and welcoming environment. This study is currently recruiting participants, so it's a great chance to get involved and receive support while also contributing to important research.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male
- • Black
- • HIV-negative
- • 18 years of age or older
- • Either residing in Prince George's County Maryland, or having a sexual partner in Prince George's County Maryland within the past year.
- • Exclusion Criteria
- • HIV Positive
- • Refusal of HIV testing
About George Mason University
George Mason University, a prominent public research institution located in Fairfax, Virginia, is dedicated to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university conducts a wide range of clinical trials aimed at addressing pressing health challenges and enhancing patient care. Leveraging its diverse faculty expertise and state-of-the-art facilities, George Mason University fosters a dynamic environment for scientific inquiry and discovery, ultimately contributing to the development of effective therapies and interventions that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fairfax, Virginia, United States
Patients applied
Trial Officials
Rodman Turpin, PhD
Principal Investigator
George Mason University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported